ClinicalTrials.gg
Status unknownNCT05533931Updated Sep 9, 2022

Resistive Breathing Versus Inspiratory Hold Technique in Patients With Chronic Bronchitis

An interventional study of Resistive Breathing Training group and inspiratory hold technique in Chronic Bronchitis, sponsored by Riphah International University. Status unknown at 1 site in Pakistan. Open to participants aged 45 Years to 60 Years. Per ClinicalTrials.gov, last updated 2022-09-09.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
45 Years to 60 Years
Sex
All
01

Study summary

The aim of the study is to determine the importance and impact of resistive breathing techniques versus inspiratory hold techniques in patients with chronic bronchitis and specially to find out if there are any changes seen in results measured via the incentive spirometer.

Read the detailed description

Chronic Bronchitis (CB) is defined as a chronic cough and sputum production for at least 3 months a year for 2 consecutive years. It is covered under the umbrella term of Chronic Obstructive Pulmonary Disease (COPD). Chronic bronchitis is thought to be caused by overproduction and hypersecretion of mucus by goblet cells. Epithelial cells lining the airway response to toxic, infectious stimuli by releasing inflammatory mediators and e.g. pro-inflammatory cytokines. During an acute exacerbation of chronic bronchitis, the bronchial mucous membrane becomes hyperemic and edematous with diminished bronchial mucociliary function. This, in turn, leads to airflow impediment because of

luminal obstruction to small airways. The airways become clogged by debris and this further increases the irritation. The characteristic cough of bronchitis is caused by the copious secretion of mucus in chronic bronchitis. Pseudostratified epithelium, highlighting the pseudostratified epithelial cells, goblets cells (shown in blue), then underlying connective tissue.(3) To determine the importance and impact of resistive breathing techniques versus inspiratory hold techniques in patients with chronic bronchitis and specially to find out if there are any changes seen in results measured via incentive spirometer. There are few studies done over it whereas purpose of this research work is to compare these techniques to get better results.

02

Conditions studied

  • Chronic Bronchitis

Browse trials for

Keywords

  • lung infection
  • resistive breathing
  • inspiratory hold technique
03

In context

Bronchitis, Chronic

209 studies on the registry are indexed under Bronchitis, Chronic; 14 are open to participants now.

This study's planned enrollment of 26 is below the median of 101 across 154 interventional studies indexed under Bronchitis, Chronic.

Browse Bronchitis, Chronic studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Diagnosed with chronic bronchitis

      • Clinically stable patients.
      • Both genders.
      • Age 45 to 60 years.
      • Pink puffers included in this study
      • Clients that are involved in research are not allowed for other interventional therapies. They can take their regular medications.
      • Patients diagnosed at least 2 years ago with bronchitis.

Exclusion criteria

Exclusion Criteria:

    • Presence of any genetic disorders (cystic fibrosis).

      • Recent spinal / chest surgery
      • Cardiac issues
      • Fractures of vertebra caused by osteoporosis.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
26 participants (estimated)

Study arms

  • Experimental
    Resistive Breathing Training group

    The patients performed two sessions each of 15 minutes session of resistive breathing for four days a week for six weeks using an inspiratory resistive device. Ask patient to take long slow inspirations while breathing through the resistive device

    Other: Resistive Breathing Training group

  • Active comparator
    inspiratory hold technique

    With the patient in a comfortable position such as side lying or reclined, the therapist may assist the patient by placing both hands on abdominal area to provide proprioceptive feedback. Then in a relaxed tone of voice therapist instructs the patient to sniff quickly through the nose three times with slow, relaxed exhalations

    Other: inspiratory hold technique

Interventions

  • OtherResistive Breathing Training group

    The patients performed two sessions each of 15 minutes session of resistive breathing for four days a week for six weeks using an inspiratory resistive device. Ask patient to take long slow inspirations while breathing through the resistive device

  • Otherinspiratory hold technique

    With the patient in a comfortable position such as side lying or reclined, the therapist may assist the patient by placing both hands on abdominal area to provide proprioceptive feedback. Then in a relaxed tone of voice therapist instructs the patient to sniff quickly through the nose three times with slow, relaxed exhalations

06

What researchers measure

Primary outcomes

  1. oxygen saturation

    amount of oxygen traveling through your body with your red blood cells. Changes will be assessed at baseline, 3rd week and 6th weeks measured

    Time frame: Changes will be assessed at baseline, 3rd week and 6th weeks measured

  2. Forced expiratory volume in one second

    amount of air expired in first one second. Changes will be assessed at baseline, 3rd week and 6th weeks measured

    Time frame: Changes will be assessed at baseline, 3rd week and 6th weeks measured

  3. Forced vital capacity

    the total amount of air exhaled during the FEV test. Changes will be assessed at baseline, 3rd week and 6th weeks measured

    Time frame: Changes will be assessed at baseline, 3rd week and 6th weeks measured

  4. FEV1/FVC ratio

    the amount of air exhaled in the first second divided by all of the air exhaled during a maximal exhalation.

    Time frame: 6 weeks

  5. shortness of breath measured through borge scale of dyspnea

    shortness of breath. Changes will be assessed at baseline, 3rd week and 6th weeks measured

    Time frame: Changes will be assessed at baseline, 3rd week and 6th weeks measured

  6. SGRQ questionnaire

    how breathing problems effects quality of life . Changes will be assessed at baseline, 3rd week and 6th weeks measured

    Time frame: Changes will be assessed at baseline, 3rd week and 6th weeks measured

07

Study locations

1 site
  • Mayo hospital
    Lahore, Punjab 53700, Pakistan
    • Wajeeha Zia, MSPT · Principal investigator
08

References and documents

Publications

  • Wang G, Hallberg J, Um Bergstrom P, Janson C, Pershagen G, Gruzieva O, van Hage M, Georgelis A, Bergstrom A, Kull I, Linden A, Melen E. Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE. Eur Respir J. 2021 Mar 4;57(3):2002120. doi: 10.1183/13993003.02120-2020. Print 2021 Mar. PubMed 33184115 ↗
  • Andelid K, Ost K, Andersson A, Mohamed E, Jevnikar Z, Vanfleteren LEGW, Goransson M. Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis. Respir Res. 2021 Jun 7;22(1):172. doi: 10.1186/s12931-021-01762-4. PubMed 34098956 ↗
  • Samaha E, Vierlinger K, Weinhappel W, Godnic-Cvar J, Nohammer C, Koczan D, Thiesen HJ, Yanai H, Fraifeld VE, Ziesche R. Expression Profiling Suggests Loss of Surface Integrity and Failure of Regenerative Repair as Major Driving Forces for Chronic Obstructive Pulmonary Disease Progression. Am J Respir Cell Mol Biol. 2021 Apr;64(4):441-452. doi: 10.1165/rcmb.2020-0270OC. PubMed 33524306 ↗
  • Belman MJ, Thomas SG, Lewis MI. Resistive breathing training in patients with chronic obstructive pulmonary disease. Chest. 1986 Nov;90(5):662-9. doi: 10.1378/chest.90.5.662. PubMed 3769566 ↗
  • Kim HK, Alhammouri MT, Mokhtar YM, Pinsky MR. Estimating left ventricular contractility using inspiratory-hold maneuvers. Intensive Care Med. 2007 Jan;33(1):181-9. doi: 10.1007/s00134-006-0443-8. Epub 2006 Nov 14. PubMed 17103142 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05533931
Responsible party
Sponsor
First posted
Sep 9, 2022
Start date
Sep 2022 (estimated)
Primary completion
Sep 2022 (estimated)
Completion
Sep 2022 (estimated)
Last update
Sep 9, 2022

Study contacts

Ghazal Jamshaid, MS CPPT
Contact
ghazaljamshaid141@gmail.com
03040404851
Wajeeha Zia, MSPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion